Introducing pharma's top KOLs

 Posted 13 September 2024 PM

They are the most sought-after voices in industry - the Key Opinion Leaders shaping the future of patient care - and a new analysis has lifted the lid on exactly who they are and how much pharma is paying for their services, making this story our top read this week.

The data came from the latest round of Medicines Australia Transparency Reporting but the analysis was made by a new competitive intelligence tool created by Commercial Eyes, called TRoVE. It revealed cardiologist Karam Kostner was the highest paid HCP during the six month reporting period extending from November last year. Four companies invested $87,000 for his expert advice. The runner-up was GP Daniel Nour who earned $80,000 from just one company, Pfizer. See the full list in: Industry's top KOLs by spend

To see the whole article, please login